US Stock MarketDetailed Quotes

OMER Omeros

Watchlist
  • 9.180
  • +0.060+0.66%
Close Feb 14 16:00 ET
  • 9.140
  • -0.040-0.44%
Post 20:01 ET
531.98MMarket Cap-3.99P/E (TTM)

About Omeros Company

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Company Profile

SymbolOMER
Company NameOmeros
Listing DateOct 8, 2009
Issue Price10.00
Founded1994
CEODr. Gregory A. Demopulos,M.D.
MarketNASDAQ
Employees198
Fiscal Year Ends12-31
AddressThe Omeros Building,201 Elliott Avenue West
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98119
Phone1-206-676-5000
Websitehttp://www.omeros.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gregory A. Demopulos,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 7.69M
  • Nadia Dac
  • Vice President and Chief Commercial Officer
  • --
  • David J. Borges
  • Vice President, Finance, Chief Accounting Officer, Principal Financial Officer and Treasurer
  • --
  • Dr. Catherine A. Melfi, PhD
  • Vice President, Regulatory Affairs and Quality Systems and Chief Regulatory Officer
  • --
  • Dr. George A. Gaitanaris, M.D.,PhD
  • Vice President, Science and Chief Scientific Officer
  • --
  • Dr. Andreas Grauer, M.D.
  • Vice President and Chief Medical Officer
  • --
  • Dr. Mariana N. Dimitrova
  • Vice President, Chemistry, Manufacturing and Controls
  • --
  • Dr. J. Whitaker, J.D.,M.D.
  • Vice President, Clinical Development
  • --
  • Peter W. Williams
  • Vice President, Human Resources
  • --
  • Peter B. Cancelmo
  • Vice President, General Counsel and Corporate Secretary
  • 852.63K
  • Diana T. Perkinson
  • Director
  • 174.66K
  • Dr. Peter A. Demopulos,M.D.
  • Director
  • 122.60K
  • Thomas J. Cable
  • Lead Independent Director
  • 177.60K
  • Dr. Rajiv Shah, M.D.
  • Independent Director
  • 140.10K
  • Dr. Leroy E. Hood,M.D.,Ph.
  • Independent Director
  • 135.10K
  • Dr. Thomas F. Bumol, PhD
  • Independent Director
  • 127.60K
  • Arnold C. Hanish
  • Independent Director
  • 137.60K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%
Bitfarms
BITF
+1.43%

Unlock the Full List